Shriram Finance Limited (NSE:SHRIRAMFIN)
India flag India · Delayed Price · Currency is INR
614.20
-16.65 (-2.64%)
Aug 1, 2025, 3:30 PM IST

Theseus Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212017 - 2021
Period Ending
Aug '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2017 - 2021
1,155,2591,233,250886,946471,722307,067359,828
Upgrade
Market Cap Growth
21.36%39.04%88.02%53.62%-14.66%139.21%
Upgrade
PE Ratio
11.9212.9112.047.8511.2914.40
Upgrade
PS Ratio
6.276.895.743.535.046.98
Upgrade
PB Ratio
2.052.181.791.081.181.66
Upgrade
Debt / Equity Ratio
3.173.173.062.943.564.16
Upgrade
Quick Ratio
-2.412.322.112.322.37
Upgrade
Current Ratio
-2.512.342.192.422.49
Upgrade
Asset Turnover
-0.070.070.080.050.04
Upgrade
Return on Equity (ROE)
18.11%17.78%15.40%17.23%11.38%12.54%
Upgrade
Return on Assets (ROA)
-3.48%3.14%3.41%2.00%2.05%
Upgrade
Earnings Yield
8.39%7.75%8.30%12.74%8.86%6.94%
Upgrade
Earnings Yield
8.39%7.75%8.30%12.74%8.86%6.94%
Upgrade
FCF Yield
--35.60%-35.46%-37.62%-28.97%-11.85%
Upgrade
Dividend Yield
1.57%1.52%1.95%2.92%1.87%1.38%
Upgrade
Payout Ratio
-19.46%25.45%9.36%31.30%6.11%
Upgrade
Buyback Yield / Dilution
-0.02%-0.02%-0.08%-41.28%-8.08%-8.55%
Upgrade
Total Shareholder Return
1.55%1.49%1.86%-38.36%-6.21%-7.17%
Upgrade
Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.